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Abstract
Soil-transmitted helminthiases (STH) are one of 17 neglected tropical diseases (NTDs) ear-
marked for control or elimination by 2020 in the WHO’s Roadmap on NTDs. Deworming pro-
grams for STH have thus far been focused on treating pre-school and school-aged children;
however, there is a growing consensus that to achieve elimination of STH transmission, pro-
grams must also target adults, potentially through community-wide mass drug administra-
tion (MDA). There is currently a gap in the literature on what components are required to
deliver community-wide MDA for STH in order to achieve high intervention reach and
uptake. Nested within the TUMIKIA Project, a cluster randomized trial in Kenya evaluating
the effectiveness of school-based deworming versus community-wide MDA, we collected
qualitative data from program implementers and recipients in eight clusters where commu-
nity-wide MDA was delivered. Data collection included semi-structured in-depth interviews
(n = 72) and focus group discussions (n = 32). A conceptual framework for drug distribution
was constructed to help build an analysis codebook. Case memos were developed for each
top-level theme. Community-wide MDA for STH was perceived as a complex intervention
with key administrative and social mobilization domains. Key actionable themes included:
(1) developing an efficient strategy to allocate reasonable workload for implementers to
cover all targeted households; (2) maximizing community drug distributors’ motivation
through promoting belief in the effectiveness of the intervention and providing sufficient
financial incentives; (3) developing effective capacity building strategies for implementers;
and (4) implementing a context-adapted community engagement strategy that leverages
existing community structures and takes into consideration past community experiences of
MDAs. Transitioning from STH control to elimination goals requires significant planning and
action to ensure community-wide MDA is delivered with sufficient reach and uptake. We
PLOS NEGLECTED TROPICAL DISEASES
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0008258 April 20, 2020 1 / 18
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Legge H, Kepha S, Prochazka M, Halliday
K, Pullan R, Gwayi-Chore M-C, et al. (2020)
Implementer and recipient perspectives of
community-wide mass drug administration for
soil-transmitted helminths in Kwale County, Kenya.
PLoS Negl Trop Dis 14(4): e0008258. https://doi.
org/10.1371/journal.pntd.0008258
Editor: Ana Lourdes Sanchez, Brock University,
CANADA
Received: October 29, 2019
Accepted: March 27, 2020
Published: April 20, 2020
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pntd.0008258
Copyright: © 2020 Legge et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Participants did not
provide consent to have their full audio transcripts
made publicly available. Furthermore participants
present findings that can inform national deworming programs to increase intervention deliv-
ery capacity.
Author summary
Infections by soil-transmitted worms are common in tropical and subtropical areas. Con-
trol strategies usually involve distributing deworming drugs to children, who are most
affected. However, recent evidence suggests that distributing these drugs to whole com-
munities, including adults, might help to achieve the elimination of these worms as a pub-
lic health problem. As part of a large trial in Kenya evaluating the distribution of
deworming drugs to communities, we conducted a qualitative study to explore the per-
spectives of drug delivery among drug distributors and recipient communities. We con-
ducted and analyzed in-depth interviews and focus group discussions. For community
deworming to be implemented well, it requires distributors to be highly motivated and
follow a plan that fits well with the characteristics of the target community. In order to
accept the deworming drugs, communities need to know about the health problem and
the intervention, and trust the delivery system. These findings should prove useful to
national deworming programs planning to distribute drugs to whole communities when
developing their delivery strategies.
Introduction
Current control strategies for soil transmitted helminthiases (STH) are primarily focused on
reducing morbidity amongst preschool-age children (PSAC) and school-aged children (SAC)
using age-targeted preventive chemotherapy [1]. In many settings however, school-based
deworming is insufficient to control infection at the community-level, since transmission may
be maintained by infected adults. Recent evidence suggests that using a community-wide mass
drug administration (MDA) strategy might substantially reduce transmission, potentially
eliminating STH as a public health problem [2,3]. Given the momentum for elimination of
STH in the global health community, there is a need to identify the most effective and sustain-
able strategy to deliver preventative chemotherapy (PC), with a potential shift from age-tar-
geted to community-wide MDA [4].
Community-wide MDA is a key intervention for the control and elimination of several
NTDs, including lymphatic filariasis (LF), onchocerciasis, trachoma, and schistosomiasis.
Multiple studies have focused on the effectiveness and acceptability of MDA for these diseases
[5–8]; however, there is limited evidence supporting the use of community-wide MDA for
STH. The TUMIKIA Project, conducted in Kenya, was the first cluster randomized control
trial assessing the effectiveness, equity, and cost of school-based versus community-wide treat-
ment strategies on the prevalence and intensity of STH infection [9,10]. The impact results
concluded that community-wide MDA was more effective in reducing hookworm prevalence
and intensity across all age groups than school-based delivery, providing much needed evi-
dence on the feasibility and effectiveness of community-wide MDA for STH control [9].
Given this emerging scientific evidence and policy environment supporting more compre-
hensive efforts to control STH, national NTD control programs aiming to shift from school-
based to community-wide delivery platforms will need guidance on how best to implement
and monitor these interventions. Moreover, understanding perspectives of key actors involved
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in MDA implementation is necessary to inform programmatic improvements and help meet
treatment coverage targets. Within the TUMIKIA Project, we conducted a qualitative study to
explore perspectives of implementers and recipients of community-wide MDA for STH on
various implementation aspects. In this paper, we present the results of an analysis focused on
understanding key components of the reach and uptake of the intervention.
Methods
Ethics statement
Ethical approval was obtained from the Kenya Medical Research Institute (KEMRI) Ethics
Review Committee (SSC No. 2826) and the London School of Hygiene & Tropical Medicine
(LSHTM) Ethics Committee (7177). TUMIKIA is registered with ClinicalTrials.gov
NCT02397772. An information sheet was provided to all individuals invited to participate in
the study in Swahili. Participants underwent written informed consent and agreed to have
IDIs or FGDs audio-recorded. Illiterate participants or participants who did not speak Swahili
had the consent sheet read to them in their preferred language by or in the presence of an inde-
pendent, literate witness. The participant then either signed or provided a thumb print,
observed by the witness who also provided their signature. During transcription, participant
names were replaced with alphanumeric unique identifiers to ensure anonymity and
confidentiality.
Study setting
The TUMIKIA Project was a community cluster randomized trial evaluating school-based and
community-wide treatment platforms for STH, conducted in Kwale County, Kenya between
2015 and 2017. Full details of the trial design are published elsewhere [9–11]. In brief, standard
school-based MDA using albendazole was delivered in the control arm while in the interven-
tion arms, community-wide MDA with albendazole was delivered annually and bi-annually
via door-to-door distribution over an eight-day period. The distribution period of the commu-
nity-wide MDA was decided upon in collaboration with the Ministry of Health (MoH) and
based on the timeline of previous MDAs in the study setting. Delivery leveraged MoH commu-
nity health service structures by recruiting existing frontline health workers, known as Com-
munity health volunteers (CHVs), as drug distributors. CHV selection was overseen by the
County Public Health Office and organized by the Community Health Assistants (CHAs),
according to standardized guidelines for selection, which included community participation
in nomination of individuals. In all but a few exceptions CHVs were selected from the same
community in which they lived and as a result were treating in their own village. CHVs were
required to cover approximately 120 households across eight days, and were paid using a per-
formance-based strategy (500KSH per day–approximately USD$5.00 –consistent with nation-
ally-recognized daily subsistence allowance rates). Terms of employment for CHVs were
developed in consultation with the MoH and local government. Before each implementation
round, a short training cascade was delivered, which provided general information on STH,
community mobilization, planning and implementation of MDA, and completion of treat-
ment registers. This was delivered through the sub-county to (CHAs), who managed the
intervention delivery in assigned clusters. CHAs were then responsible for training and subse-
quently supervising CHVs, who were responsible for delivering community-wide MDA door-
to-door. Community mobilization and engagement was conducted through forums involving
chiefs, ward administrators and CHAs, and meetings and door-to-door visits conducted by vil-
lage elders.
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Qualitative data for this study were collected from implementers and recipients from the
bi-annual community-wide treatment arm of the project in August 2016, one year after initia-
tion of the trial. For the purpose of this study, “recipients” include community members,
including opinion leaders within TUMIKIA intervention clusters. “Implementers” include
CHAs and CHVs. Within the Kenyan health system, CHAs and CHVs are key stakeholders
who support the delivery of community-based health promotion and prevention activities [12].
Participant sampling
A total of eight villages were selected across the 80 intervention clusters (equivalent to MoH
community units comprising approximately 1000 households each). These were purposively
sampled on the basis of treatment uptake, sub-county and rural/peri-urban location. Within
each of the four sub-counties, two clusters were stratified as high or low coverage based on the
results of coverage surveys from the previous rounds of MDA. A village was selected from
each of the eight resulting strata, with an aim to select a range of peri-urban, rural and remote
communities. Within selected villages, CHVs, opinion leaders, and community members were
purposefully selected according to availability and participation in the MDA. Selection of opin-
ion leaders aimed to cut across various influential groups in the community, including reli-
gious leaders (Muslim and Christian), teachers, chiefs, village elders, businessmen and political
leaders. Semi-structured in-depth interviews (IDIs) were held with community opinion lead-
ers, CHAs and CHVs. In addition, focus group discussions (FGDs) were conducted with com-
munity members; up to 12 participants were invited to each FGD. Groups were structured
based on age (18–34, >34) and sex. Eligibility criteria included age�18 years and willingness
to participate in the study. Participants completed a brief demographic questionnaire and
received a 300KSH (approximately USD$3.00) transport compensation.
Data collection
The IDIs and FGDs were conducted within three months of the third round of MDA by a facilita-
tor in the preferred language of the participants, including Swahili, Duruma and Digo. Interview
and discussion guides were developed based on literature reviews and adapted from past studies
conducted on community-wide MDA [13]. Each FGD was conducted by two facilitators, one of
whom asked questions while the other took notes. Both IDIs and FGDs were audio recorded and
held in private areas to ensure participants’ confidentiality. Audio recordings were transcribed
verbatim in the interview language and then translated into English by trained field officers.
Data management and analysis
A conceptual framework mapping out the key components of community-wide MDA was
developed as a tool to shape the codebook and coding process. Development of the framework
was based on existing literature and authors’ implementation experience regarding delivery of
MDA programs [14–17]. The framework (Fig 1) presents key inputs and contextual factors rel-
evant to the planning and delivery of MDA leading to two outputs: “reach” and “uptake”. We
define reach as the ability of implementers to make contact with target individuals and offer
them treatment. Uptake, often referred to as compliance, is defined as the successful receipt of
the tablet by target individuals (i.e. swallowing the tablet) once offered.
Coding was conducted using NVivo 12.0. A preliminary cycle of coding allowed for the
codebook to be refined with additional codes added or removed as analysts (HL and SK)
became familiar with the data. Once this cycle was complete, the codebook was finalized and
used to complete coding of all study transcripts. A subset of transcripts was coded by all
assigned coders and was assessed to ensure that high inter-coder reliability was being
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maintained (k>0.65). The process was repeated until the level of agreement reached was
acceptable. After all transcripts were coded, data aggregation queries were used to develop ana-
lytic case memos using Microsoft Word. Written case memos were stratified by respondent
type and structured according to main themes and sub-themes within the conceptual frame-
work. While our sampling approach included selecting villages from high and low coverage
clusters to ensure maximum variability, we did not compare themes by coverage since the
focus of the study was on understanding factors related to successful MDA implementation,
regardless of reported coverage. Throughout the process, analysts met regularly to discuss
codebook updates, case memos and thematic saturation. Results of this analysis are presented
in a narrative summary of key themes, a conceptual framework, and discussed as actionable
recommendations. Representative quotes were embedded within the results to exemplify
themes, with minor grammatical alterations to improve readability.
Results
A total of 411 respondents were included in this study (Table 1). Results are organized in two
sections: reach of households within the target population, and uptake of deworming drugs by
community members.
Fig 1. Conceptual framework for delivery of community-wide mass drug administration.
https://doi.org/10.1371/journal.pntd.0008258.g001
Table 1. Types of interviews conducted and number of participants per interview.
Interview Type Total number (N = 411)
FGD� Young women (18–34 years) 77 (k = 8)
Young men (18–34 years) 87 (k = 8)
Adult women (>34 years) 91 (k = 9)
Adult men (>34 years) 84 (k = 7)
IDI Opinion leaders 32
Community health assistants (supervisors) 8
Community health volunteers (drug distributors) 32
� “k” represents number of FGDs conducted per respondent type. Each FGD group included 8–12 individuals.
https://doi.org/10.1371/journal.pntd.0008258.t001
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Reach
Successful delivery of community-wide MDA was seen by respondents to be dependent on
adequate planning of logistical and administrative aspects of the intervention. Key attributes to
achieve high reach included: (1) a well-trained and motivated workforce of community drug
distributors; (2) a flexible and responsive implementation strategy; and (3) understanding and
addressing factors that shape community availability.
“Let them be trained and be recognized”: Implementer training and
motivation
Implementers described factors that influenced their motivation to participate in the MDA
and their intention to participate in future MDAs. Primary among these was their belief in the
effectiveness of the intervention, which provided them with the opportunity to improve the
health of their community, their sense of self-efficacy in carrying out their roles, and the level
of financial and non-financial incentives, such as knowledge and recognition offered to them
by participating in the intervention:
“The reason that [I will] join the drug distribution next time is that I want my people to get
the cure, because if I left this to those [CHVs] who are new in this area [community members]
will miss the drugs.” (CHV)
“I thought [the MDA] was good because good health is needed by everyone . . . good health
brings happiness. Another reason is moving in the community helps the community know
you.” (CHV)
“You also add us something. The last four days we were being given only [mobile phone
credit]. Add us at least lunch allowance . . .The thing [is] my CHVs have not been trained. So
humbly let them be trained and be recognized.” (CHA)
Implementers mentioned technically and culturally tailored training that is responsive to
their needs as being a critical component for successful MDA delivery. They agreed on the
need for training focused on developing their capacity to either manage CHVs or to be suc-
cessful distributors themselves. However, they noted that these trainings should be non-repeti-
tive, especially as implementers gain expertise with each subsequent round of MDA. For
training sessions to be successful, implementers noted that they should provide relevant and
updated information for their specific roles during MDA planning and delivery, be well-timed
(i.e. not conflicting with other MoH activities or significant cultural events), and have suffi-
cient time to cover all topics.
“Ok generally since we have been in TUMIKIA for one and a half years, they have to focus on
key areas mostly to concentrate on forms, because the issue of understanding the helminths is
now clear, so they should concentrate on forms when there any changes. Because the last time
we did deworming the forms were different from the ones we used, so you get problems.”
(CHA)
“Either they increase the number of days or they increase the CHVs”:
adaptable implementation strategy and efficient supply chain
Given the complexity of implementing community-wide MDA and the perceived short time-
line for drug administration (8 days), respondents often mentioned efficiency and equity of
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workload as key factors for consideration while developing the MDA implementation strategy.
For many CHAs and CHVs, workload assignment was a major priority, including the number
of days they were provided to administer deworming medicines and the size of the team that
was assigned to plan, deliver, and monitor treatment. Across all locations, workload was com-
monly referenced as being excessive for implementers who noted that the magnitude of the
geographical area and target population being covered affected their work efficiency:
“The time [for distribution] was short . . .the households were not many but they were far
apart. . . It’s possible to just do the return in one day for the person [going to a village] which
is near. . ., but for someone like me who come from far, [it] can be a problem.” (CHV)
A common suggestion was to increase the number of CHVs and/or the number of days for
treatment to cover the allotted number of houses, especially if a CHV was assigned large vil-
lages or ones that were far from their own homes:
“I can say these days are not enough. . . Every time they ask why these villages are not always
covered I told them I was doing it alone and it’s a big village, so it’s either they increase the
number of days or they increase the CHVs” (CHV)
Implementers also emphasized the importance of ensuring that key materials were pro-
vided in adequate amounts at each point of the supply chain, especially drugs and treatment
forms. CHVs emphasized the need for travel distance between storage points to be minimized,
highlighting that long distances from storage points to target communities resulted in
increased time spent travelling or greater expenditure on transport.
“[By] the time I have finished the drugs I am very far from where I collect the drugs. I had to
walk or use [a] motorbike to come for the drugs.” (CHV)
For CHAs, in addition to geographical barriers, they noted that their areas of supervision
should be contiguous and the number of clusters assigned to one CHA should be minimized
for ease of providing operational and technical support to their CHVs. Additionally, imple-
menters noted the importance of considering other ongoing community health priorities by
MoH and scheduling treatment days to take place around religious or cultural events (e.g.
Ramadan).
As an additional dimension to workload, implementer respondents also highlighted how
interactions with household members were often time-consuming due to education efforts
taking place within households, including time set aside to respond to concerns before house-
hold members accepted treatment. Respondents linked these interactions with longer working
hours which in turn had the potential to impact overall reach. Despite the intense workload,
CHVs worked long hours to ensure that they reached all households.
“You leave in the morning and come back at night because all that process of reaching a
household–you introduce yourself, explain what you have gone to do and then you convince
them until they agree. It takes a long time.” (CHV)
Several implementers perceived community-wide engagement prior to MDA as the best
method to reduce the need for “doorstep” education, further increasing their efficiency and
improving reach:
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“What I think is, before the distribution just like the way the drugs are being distributed the
information should be passed the same way.. this makes the distributors work easy as they will
save time explaining.” (CHV)
“You won’t find them”: community availability
Respondents perceived the availability of community members as a key determinant of reach.
Community availability was hindered by competing responsibilities, including school, casual
labor, or employment that led members to be absent from the household:
“If only one person and the guide were to distribute to all houses maybe they arrive at around
noon when most women go to the shamba (garden) and the children have gone to play so it
was difficult.” (Community member, youth male FGD)
“You can revisit even three times but you won’t find them. Because in our area if a man is not
employed he goes to [the] quarry and mine stones.” (CHV)
Migration of entire households was also cited as representing a challenge for CHVs as it
sometimes required multiple trips to confirm whether a household was truly vacant or simply
absent at the time of the visit.
“Whenever I went [to the household] he was not there, until the last day when the neighbor
told me that I was tiring myself and that he was in Mombasa.” (CHV)
More broadly, revisiting households due to unavailability of community members (CHVs
were instructed not to leave tablets for unavailable household members, and instead conduct
call-backs at a later date) was time-consuming for implementers, especially when returning to
more isolated households as CHVs were forced to dedicate time and resources to trace rela-
tively few individuals.
Implementers, for the most part, did not perceive engagement activities to be effective in
promoting community availability as they could only relay a wide range of days over which
drug administration would take place. However, community respondents suggested that if it
was possible for community engagement messages to include more precise information on
when drug delivery would occur, this could potentially promote community availability.
“The way [to deliver community engagement activities] which could have been used is that
people could have been called for a meeting and then be told . . .we have called you to make
you aware that there will be deworming drug distribution on this date and those who will
bring the drugs will be in company of [the] chairman. That could have made people aware
and stay at their homes that mentioned day and date waiting for the drugs.” (Opinion leader)
Uptake
Trust and demand were perceived to be key and consistent determinants of MDA uptake.
Community members referred to these to validate their own or others’ decisions whether to
accept the deworming drugs, or storing or disposing them after distribution. Both trust and
demand emerged as multidimensional and interrelated themes, involving: (1) perceived safety,
rumors and beliefs about the deworming medicines; (2) perceived effectiveness and need for
deworming and risk of STH infection; and (3) community awareness and knowledge of the
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intervention. Community engagement activities involving agents of influence in the commu-
nity were important to ensure uptake given their ability to build trust and demand.
“Medicine, or other things?”: perceived safety, rumors and beliefs
Perceiving deworming drugs as safe was key for MDA uptake. Individual perceptions on safety
among community members were shaped by past experiences taking these drugs or those
from other MDA campaigns. These perceptions were based on specific experiences of others
in the community, including children or neighbors, who had experienced side effects in the
past. Under these circumstances, taking the medication was framed as an act of trust, over-
coming the fears associated with perceived side effects:
“They will [be] interested in taking [the drugs] because even those who did not take, they are
asking themselves why our fellows used the drugs and they were not affected. So there are
some who will gain courage to use the drugs.” (Community member, youth male FGD)
Additionally, fearful perceptions and beliefs about MDA were fueled by rumors circulated
in the community. Respondents mentioned that their communities believed MDA did not
intend to control STH, but that it was a strategy for family planning, or for another harmful
purpose. These beliefs affected trust and demand for the intervention:
“Some swallowed the tablets some didn’t. Those who did not some said they heard rumors
that the drugs are meant for family planning and they can cause strokes and elephantiasis”
(Community member, youth female FGD)
“When one is given the drugs they just take the drug to end the conversation [with CHVs] and
then later they throw it, because the drug may be illuminati wanting to take their blood.”
(Community member, youth male FGD)
Even in the presence of information that directly addressed rumors, some community
members refused to take the drugs. This behavior appeared to stem from lack of familiarity
with CHVs and deep mistrust and resistance to the intervention:
“Anything related to health, the villager believes on the doctor, like the drugs. But when I take
them as me, [the villagers] will have doubts, has this person brought me medicine, or other
things?” (CHV)
“They may be distributed by my enemy and he/she may poison me or add some other drugs
on it.” (Community member, youth male FGD)
Knowing the CHVs as members of the community beforehand also influenced trust, as did
their formal appearance, which affected the perceived legitimacy of the intervention:
“If they [CHVs] are all strangers there will be resistance.” (Community member, adult male FGD)
“The distributors should have good appearance and look attractive because some distributors
approach you when very rough, even if you don’t have the appetite of taking the drugs.” (Com-
munity member, youth male FGD)
Implementers considered formal uniforms such as branded project t-shirts and bags to be
of particular value when drug distributors were not familiar to their assigned community:
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“T-shirt[s] were not [available] so we just distributed [the drugs and] because we are known
to the community people believed us. But if it were in the village that we were not known it
would have [had] effects.” (CHV)
“Maybe I am being treated for an illness I don’t have!”: perceived
effectiveness and need
Despite the rumors and fears, most recipients appeared to perceive MDA as effective for treat-
ing helminth infections, based on their own or others’ previous experiences. Effectiveness was
occasionally linked to the perceived resolution of symptoms like diarrhea, cramping, poor
appetite, abdominal distention, and the visible passage of worms with stools. Some participants
mentioned worm infections were now less common in the community, and that the need to
seek care for worm infections among children was now rare. These perceptions of effectiveness
consolidated demand for the intervention:
“I think it was fine because many people have less problems since we had children with worms
and after taking the drugs and slept at night, the worms were getting out and now the prob-
lems have ceased. So the drugs have helped people a lot.” (Opinion Leader)
The demand for community-wide MDA targeting STH was also justified by the perceived
environmental risk of infection given poor water and sanitation infrastructure:
“In our village the toilet is only one, so without giving the drugs for worms the entire village
will have worms.” (Opinion Leader)
In contrast, a few respondents questioned their need for taking medications if they were
asymptomatic, or did not have an infection confirmed with diagnostics, perceiving distribut-
ing drugs to the whole community as an ineffective strategy:
“But the drugs were given to everybody, how did they know each and every one has worms?
The process was not perfect at all. Maybe I am being treated for an illness I don’t have!” (Com-
munity member, youth male FGD)
The recurrent nature of MDA campaigns also affected the perceived effectiveness of
deworming medicines, particularly in communities that previously received MDA for other
diseases, challenging both trust and demand. Community members were rarely able to discern
between the focus of current and previous campaigns for other infections.
“Some said these drugs are not for worms and that they are brought frequently, if they are for
worms they were brought before, so why are they being brought again? So it’s like some had
doubt.” (Opinion Leader)
“Reduce the speculations”: community engagement activities, community
awareness and knowledge
When discussing drivers for mistrust and lack of demand for treatment, respondents suggested
poor community awareness and knowledge about the MDA, since this could facilitate rumors,
false beliefs, and affect perceptions of need. Implementers and recipients alike perceived com-
munity engagement activities as acceptable and effective strategies to improve uptake via
awareness, knowledge and trust-building. Respondents highlighted that community
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engagement activities were reliant on the participation of community authorities who acti-
vated a cascade of social mobilization across pre-existing community leadership structures,
including village chiefs, sub-chiefs, and elders. Limited involvement of any of these groups
could jeopardize the dissemination of engagement messages, and thus negatively impact MDA
uptake:
“We should be informed through public meetings by chairman and this will lead people to
know the importance because if it happens [that] a CHV comes to my home without inform-
ing me, no way I will consume the drugs.” (Community member, youth male FGD)
Because these stakeholders are influential figures that inspire respect and authority, their
involvement was key to build trust:
“They [the drugs] were left behind for me, and when I came back my wife gave them back to
me. I asked who had left them and I was told, it’s [CVH name]. I remembered that the chair-
man had told me about it, I didn’t hesitate or throw them away.” (Community member,
youth male FGD)
“When the day reaches and the distributor reaches your house you will remember, oh, there’s
a day that the chief said there are drugs that will be distributed.” (Community member, youth
male FGD)
Sufficient spacing between community engagement activities and MDA was required to
ensure messages were sufficiently processed and circulated in the community. Preferred chan-
nels for community engagement included posters, verbal messages from personnel at health
facilities, mass messaging through radio, information delivered to children during school-
based MDA, and door-to-door messaging involving CHVs and community leaders. Simulta-
neous use of multiple channels was favored, particularly those that involved culturally-appro-
priate verbal messages, since illiteracy was reported as a frequent problem in the communities.
During drug distribution, community members expressed expectations of CHVs to act as
gatekeepers of knowledge and to provide information otherwise unavailable to them. The dis-
tribution of drugs without face-to-face interaction with a CHV was seen as insufficient to
motivate uptake. This perception was especially prevalent if CHVs left drugs at the household
for future consumption amongst absent household members:
“My father, for instance, he wasn’t at home and the drugs were left for him, we tried to explain
to him but he didn’t take [them], also I wouldn’t take [them] in the same case.” (Community
member, youth male FGD)
In addition, CHVs selected to be drug distributors were perceived by community members
to be important and intrinsically trustworthy, which in turn improved uptake.
“Since the CHV bears the name ‘daktari wa nyanjani’ (doctor) . . .they [the community] could
just accept to be given the drugs by the CHVs automatically.” (CHA)
In contrast, perceiving CHVs as misinformed, improperly trained or unable to provide suf-
ficient information led to mistrust and refusal to take the deworming medicines:
“In my village, those who did not take the drugs are there but later they used them, they
refused because the [CHV] did not have knowledge to explain to them clearly on the
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importance and use the drugs so that they can understand better.” (Community member,
youth male FGD)
While community engagement activities might adequately address perceived safety, efficacy
and lack of knowledge, deep mistrust seemed to be a systemic problem:
“Mostly here in our area ignorance is common, we get the message but we despise the message
. . .” (Community member, youth male FGD)
Discussion
This study explored the perspectives of implementers and recipients on the delivery of a com-
munity-wide MDA program for STH in Kwale County, Kenya. In this context, community-
wide MDA for STH was characterized as a complex intervention with multiple, interacting
administrative and social components. Reach of MDA depended on effective training and suf-
ficient motivation of drug distributors, an efficient supply chain, an adaptable and achievable
implementation strategy, and an adaptive response to community availability. Uptake was
driven by trust in the intervention and its implementers as well as demand for treatment.
Locally adapted community engagement activities that leveraged community structures to
increase community awareness and knowledge about the intervention were key, particularly
when tailored to address local perceptions on effectiveness and safety shaped by previous
MDAs. Our findings highlight key strategies (Table 2) that are instrumental for effective MDA
delivery and are relevant to inform planning of future community-wide MDA programs that
aim to control or eliminate STH.
Table 2. Themes associated with reach and uptake and actionable mitigation strategies.
Theme Impact on reach Impact on uptake Mitigation strategies
Development of an efficient and
reasonable workload
Workload impacts the efficiency of
administering treatment, specifically (i)
the travel to and interaction with
individual households, and (ii) the
number of days and human resources
allocated for MDA delivery
Effective interaction between drug
distributors and household members
facilitates trust
Sufficient time for callbacks increases
likelihood of directly observed treatment
Ensure the sufficiency of: number of drug
distributors and supervisors and their
allocated households, the time for MDA,
provision of transport
Plan distribution strategies so as to
maximize the availability of target
communities
Develop adaptable implementation
strategies that respond to feedback from/
needs of implementers and recipients
Motivated and appropriately
selected drug distributors
Effective recruitment and incentives
sustain motivation and performance
CHVs promote trust with recipients
when they are (i) already familiar to the
community in which they are
distributing, and (ii) identifiable through
a uniform
Develop an effective recruitment strategy
and accompany incentive structure (both
intrinsic and financial/material)
Use of drug distributors that live and work
in the area that they are from so to engender
trust
Developing effective capacity
building strategies for
implementers
Training facilitates ability to plan, deliver,
and monitor MDA
Well-trained knowledgeable CHVs
engender trust with recipients
Develop capacity building activities that
avoid repetition of material, have sufficient
time, consider varying degrees of
experience, and are scheduled to avoid
overlap with ongoing responsibilities
Design of a contextually-
relevant community
engagement strategy that
leverages existing community
structures
An engaged community has less need for
last-minute, doorstep education, thus
increasing CHV availability during
delivery
Strong community engagement strategies
impact levels of trust in the intervention
and demand for the treatment
Consider community experiences with past
MDAs, address common rumors and fears
surrounding MDA
Use existing community structures, ensure
sufficient duration and spacing of messages,
& utilize multiple communications channels
https://doi.org/10.1371/journal.pntd.0008258.t002
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First, the design of an efficient and reasonable workload strategy is key to both reach and
uptake. When implementers reported a heavy workload assignment, they directly linked this
to lower reach, as less time was available to contact all households on their treatment list and
conduct any necessary call-backs. This is supported by findings from previous studies assess-
ing MDA campaigns for LF in Ghana and Kenya, where distributors specifically highlighted
that insufficient MDA duration was linked to lower reach [18,19]. Moreover, uptake was also
impacted by overly ambitious treatment quotas as time-pressured CHVs opted to leave tablets
at households for absent individuals rather than return to ensure directly observed treatment,
which previous studies have linked to increased drug uptake [20]. In order to ensure that
workload assignment is efficiently calibrated, implementers must consider the time require-
ments for all constituent aspects of drug delivery. This includes the number of households allo-
cated to a drug distributor, the time required to collect the drugs and travel between
households, which depends on access barriers including geography, weather and transporta-
tion, the time spent at each household to educate and treat members, and the additional time
needed to conduct call-backs. In addition to this, the findings point towards the need for active
communication channels to be in place between program planners, implementers, and partici-
pants throughout the intervention that allow for stakeholder feedback to result in adaptations
in MDA planning and delivery. If any of these factors are not taken into consideration during
the planning phase of an MDA, reach and uptake could be negatively impacted.
Appropriately recruited and motivated drug distributors were another important ele-
ment of effective drug delivery. Motivation to participate and continue to participate as a drug
distributor was linked by respondents to belief in the effectiveness of the intervention, the pro-
vision of financial incentives, and their anticipation of social recognition. To retain experience
in the program and allow recruitment of high quality volunteers, programs should ensure that
drug distributors are trained, so as to understand the need for treatment, and that they are
financially incentivized to the point where the associated costs of volunteering are covered as
well as the opportunity cost of participation. These results agree with findings from a review of
qualitative studies of LF MDAs that highlighted the importance of financial and altruistic
incentives for implementer retention [17]. The identity of drug distributors was also highly
important as the recruitment of distributors from among the local community was key to the
promotion of trust between recipients and implementers, as has been previously shown by
studies on LF MDA in Kenya and Tanzania [13,21]. Further to this, the provision of official
identification materials such as a uniform or branded bags can be used to promote uptake
through inferring legitimacy on the drug distributor. This replicates outcomes reported in a
review of factors impacting MDA delivery for NTD programs, which stated that the acceptabil-
ity of the distributor among community members was increased when they were presented
wearing officially branded materials [22]. These findings piece together a set of perspectives
held by respondents that suggest that while aspects of drug delivery should be professionalized
(for example payment of drug distributors and formalized work attire) maintaining some
approaches from the community directed treatment (ComDT) model (such as drug distribu-
tors selected from within the communities in which they are working) could be beneficial to
the delivery of MDA. This is relevant to the PC-NTD community as a whole as some MDA
programs move away from the ComDT approach and towards the use of paid health workers
as drug distributors [23]. These results suggest that there are important aspects of community
participation that should not be abandoned when this transition takes place.
Locally adapted and appropriately scheduled training for implementers was seen as
being vital to their ability to carry out the basic function of their roles beyond drug administra-
tion, such as completing treatment logs and compiling coverage data. Most importantly, train-
ing was necessary in order to provide drug distributors with the requisite knowledge to explain
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the need and benefits of MDA to community members and address any concerns. Insuffi-
ciently trained drug distributors were likely to jeopardize uptake as their lack of knowledge
endangered recipients’ trust in the intervention. These findings are corroborated by studies on
MDA for LF and onchocerciasis in Tanzania, where poor training was linked by respondents
to limited ability to allay community members’ concerns on drug safety [21,24]. With the
exception of ensuring sufficient time is given towards training, previous studies have
highlighted the importance of training without providing further detail on what factors con-
tribute towards effective training [17,21]. In addition to ensuring sufficient training time, our
findings suggest that care must be given to ensure that trainings avoid excessive repetition of
well understood themes, such as basic health information, and instead focus on new elements
of the MDA such as any changes to drug delivery or M&E processes. In addition, trainers
should be aware of the varying levels of experience present amongst drug distributors and tai-
lor their trainings to ensure that all needs are catered for.
Our study also highlights the need for contextually-relevant community engagement
strategies, which appear to be vital to uptake by promoting trust and demand. The importance
of community engagement activities has been widely referenced in previous studies on MDAs for
a number of diseases including malaria, schistosomiasis, and LF [25–27]. Beyond the well-docu-
mented need to address prevailing rumors and generate demand through imparting knowledge
about the infection, our results indicate that community engagement can benefit both reach and
uptake. Interestingly, respondents discussed how a well-engaged community may have less need
for additional “doorstep” education, saving time and reducing drug distributor workload as they
have more time available to reach their allocated households. To our knowledge, considering
community engagement as a time-saving approach that might reduce workload during drug dis-
tribution has not previously been discussed in the NTD literature. This presents a unique perspec-
tive potentially relevant to programs operating in more densely populated areas where drug
administration represents a bigger portion of overall workload than travel or drug collection.
When discussing components of a successful community engagement strategy, we found
that leveraging existing community structures such as chiefs and village elders to deliver mes-
saging was vital, as it inferred legitimacy on the program and helped combat mistrust. This
finding has been widely reported in previous studies that have highlighted the role of tradi-
tional and religious leaders in promoting trust [14,28,29]. In addition, and not previously dis-
cussed in the NTD literature, is the need for appropriate spacing for community engagement
activities so as to give the messaging an opportunity to sufficiently circulate among community
members. While the precise timing would depend on the local context, this finding further
highlights the importance of forward planning for all components of an MDA program.
The negative impact that rumors and fears surrounding side-effects can have on uptake has
been extensively reported in the literature and this study adds further evidence that many of
these myths, such as fears of covert contraception or poisoning, are common across different
program and country settings [14,21,29]. However, there has been less consideration of the
drivers of these fears and how they can be addressed. Results from this study show that these
fears are often linked to previous negative experiences of past MDAs and that community
members are prone to conflate MDAs for other infections. This has implications for all MDA
programs that are implementing in areas that have previously been targeted for MDA by other
disease control programs. From these results, we recommend an increased awareness of the
history of MDAs in target communities and the delivery of community engagement activities
that directly and pre-emptively address any concerns that can be anticipated as arising from
previous experiences from past MDAs. This approach is especially important within an elimi-
nation context, as more frequent rounds of MDA may be necessary to achieve successful
outcomes.
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Limitations
This study has some limitations. Given the unique context of the TUMIKIA Project as a
research study, some responses may have been specific to the conduct of the trial; however, we
aimed to minimize the inclusion of data that was specific to trial implementation and focused
our results on aspects of MDA delivery in order to maximize the relevance of our findings to
other programs. Additionally, the data were collected in local languages; therefore, during the
translation process, some dialect-specific nuances may have been lost. It is also possible that
the three-month time period between MDA and data collection may have resulted in an
increased occurrence of recall bias among respondents. Lastly, although the purpose of the
trial was to understand community perspectives on deliver of community-wide MDA, the
study did not conduct any interviews or FGDs in non-intervention clusters to understand
their perception of the intervention.
Conclusion
Findings from this study have shown there are a number of key strategies that community-
wide MDA programs for STH should consider in order to achieve high reach and uptake.
These results will be of most relevance for STH programs that are transitioning from control
to elimination for which there is currently only limited literature examining what components
are necessary for delivery of community-wide MDA. In the context of the wider literature sur-
rounding MDA delivery and receipt, we have demonstrated that the challenges and solutions
that are prevalent in other MDA-focused disease control programs such as schistosomiasis, LF
and malaria are relevant to those faced in STH control. Our results suggest that while aspects
of drug distributor recruitment benefit from professionalization, programs should not ignore
the benefits that a ComDT approach can provide. A notable finding that adds to the literature
is the role that previous community experiences of MDA of other NTDs can play in shaping
trust in the treatment for a current STH program and the need to anticipate and preemptively
address community fears resulting from these experiences. Taken all together, these findings
suggest that a greater awareness of other PC control programs active in an area could be bene-
ficial to program managers for all diseases targeted with PC as there is significant potential for
cross-learning as well as a clear need to coordinate delivery.
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